SUBSCRIBE
SUBSCRIBE
News   Business

Elan Corporation PLC Sues as Biogen, Inc. (JOBS) Seeks Control Over Tysabri

August 7, 2009 | 
1 min read

Bookmark and Share

Reuters -- Irish drugmaker Elan Corp PLC said on Thursday it has filed suit against Biogen Idec Inc in a bid to block Biogen from gaining control of the multiple sclerosis drug Tysabri.

Alliances Legal
MORE ON THIS TOPIC
Art collage, hands and scales of justice. The concept of the law of the judge.
Legal
Former CytoDyn Officials Found Guilty of Securities Fraud
December 12, 2024
 · 
2 min read
 · 
Tristan Manalac
Podcast
Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More
December 11, 2024
 · 
1 min read
 · 
Heather McKenzie
Group Of Employees Being Fired By Their Company.
Layoffs
Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline
December 10, 2024
 · 
2 min read
 · 
Angela Gabriel
Correct decision chosing - confused man character standing on the crossroads and looking at signpost with three different directions - conceptual vector illustration
Depression
Relmada Considering ‘Strategic Alternatives’ After Failure of Depression Asset
December 9, 2024
 · 
1 min read
 · 
Heather McKenzie